News
Research news of note last week included US biotech Crinetics Pharmaceuticals releasing new Phase III data on its acromegaly drug candidate Palsonify (paltusotine). AstraZeneca announced positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback